Transcatheter Aortic Valve Replacement (TAVR)

February 12, 2020

Featured

Feasibility of Transfemoral Aortic Valve Implantation in Patients With Aortic Disease and Simultaneous or Sequential Endovascular Aortic Repair
We evaluated the feasibility of transfemoral TAVI in patients with aortic disease in combination with simultaneous or sequential EVAR.

Abstract: Objectives. Ticagrelor has proven more effective than clopidogrel at attaining a maintained suppression of high platelet reactivity (HPR) in aortic stenosis patients undergoing transcatheter aortic valve implantation (TAVI).

Abstract: Objective. Cardiac power index (CPI) is an integrative hemodynamic measure of cardiac pumping capability and is the product of the simultaneously measured mean arterial pressure and the cardiac output.

We share our center’s experience with the use of transcatheter valvular therapies in the setting of failed bioprostheses.

Abstract: Objectives. We sought to assess the position of the CoreValve Evolut R/Pro (Medtronic) with respect to the left coronary artery (LCA) ostium and evaluate the impact of implantation depth on this relationship.